Sanghadiya Rakesh Nareshbhai, M.D. – FDA Inspection, Oct 10, 2024

Record Details

This FDA Inspection record concerns Sanghadiya Rakesh Nareshbhai, M.D., with an inspection on October 10, 2024, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Sanghadiya Rakesh Nareshbhai, M.D.
Inspection Date: October 10, 2024
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Scott N. Lim (Issuing Officer)

View Company Profile

ID · f2f8652c-5a30-4321-9026-c883759cc58a

Inspection Facts

Inspection number: 1251631
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sanghadiya Rakesh Nareshbhai, M.D.

FDA Inspection

Sanghadiya Rakesh Nareshbhai, M.D.October 10, 2024

Sanghadiya Rakesh Nareshbhai, M.D. – FDA Inspection, Oct 10, 2024

Record Details

This FDA Inspection record concerns Sanghadiya Rakesh Nareshbhai, M.D., with an inspection on October 10, 2024, issued by the Office of Inspections and Investigations, covering human drugs.